Aliases & Classifications for Foot Drop

About this section

Aliases & Descriptions for Foot Drop:

Name: Foot Drop 46
 
Foot-Drop 65

External Ids:

UMLS65 C0085684

Summaries for Foot Drop

About this section
NINDS:46 Foot drop describes the inability to raise the front part of the foot due to weakness or paralysis of the muscles that lift the foot. As a result, individuals with foot drop scuff their toes along the ground or bend their knees to lift their foot higher than usual to avoid the scuffing, which causes what is called a ?steppage? gait. Foot drop can be unilateral (affecting one foot) or bilateral (affecting both feet). Foot drop is a symptom of an underlying problem and is either temporary or permanent, depending on the cause. Causes include: neurodegenerative disorders of the brain that cause muscular problems, such as multiple sclerosis, stroke, and cerebral palsy; motor neuron disorders such as polio, some forms of spinal muscular atrophy and amyotrophic lateral sclerosis (commonly known as Lou Gehrig?s disease); injury to the nerve roots, such as in spinal stenosis; peripheral nerve disorders such as Charcot-Marie-Tooth disease or acquired peripheral neuropathy; local compression or damage to the peroneal nerve as it passes across the fibular bone below the knee; and muscle disorders, such as muscular dystrophy or myositis.

MalaCards based summary: Foot Drop, also known as foot-drop, is related to hepatitis and neuronitis. An important gene associated with Foot Drop is FHL1 (Four And A Half LIM Domains 1). Affiliated tissues include bone, brain and spinal cord.

Wikipedia:68 Foot drop is a gait abnormality in which the dropping of the forefoot happens due to weakness,... more...

Related Diseases for Foot Drop

About this section

Graphical network of the top 20 diseases related to Foot Drop:



Diseases related to foot drop

Symptoms for Foot Drop

About this section

Drugs & Therapeutics for Foot Drop

About this section

Drugs for Foot Drop (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 80)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Bimatoprostapproved, investigationalPhase 4129155206-00-15311027
Synonyms:
(5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}-N-ethylhept-5-enamide
(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide
(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept-5-enamide
155206-00-1
15M
267244-98-4
5-Heptenamide,7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ehtyl-,(5Z)
AC1NSJUW
AGN 192024
AGN-192024
Bimataprost [USAN:INN:BAN]
Bimatoprost
Bimatoprost (JAN/USAN/INN)
Bimatoprost [USAN:INN:BAN]
Bimatoprostum
 
CHEBI:39562
CHEBI:51230
CHEMBL1200963
CID5311027
D02724
DB00905
DB06863
I06-1275
I06-1277
LS-181817
Latisse
Lumigan
Lumigan (TN)
NCGC00181745-01
UNII-QXS94885MZ
ZINC04474405
bimatoprostum
2
HyaluronanapprovedPhase 43629067-32-7, 9004-61-953477741, 24759
Synonyms:
Hyaluronate
Hyaluronic acid
Hyaluronic acid sodium salt
Hylartil
Hyruan Plus
Luronit
Macronan
 
Mucoitin
Nutra-HAF
Q 5AQ
Sepracoat
Sepragel Sinus
Sodium hyaluronate
Sofast
Synvisc
3
Mannitolapproved, investigationalPhase 424269-65-8453, 6251
Synonyms:
(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexaol
(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexol
(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
(L)-Mannitol
1,2,3,4,5,6-Hexanehexol
123897-58-5
133-43-7
15719_ALDRICH
15719_RIEDEL
33440_RIEDEL
33440_SIGMA
36413-61-3
4-01-00-02841 (Beilstein Handbook Reference)
5149-40-6
63559_FLUKA
63559_SIGMA
63560_FLUKA
63565_FLUKA
63565_SIGMA
69-65-8
75398-80-0
85085-15-0
87-78-5
AB1002081
AC-12776
AC1L1M49
AC1Q28E5
AI3-19511
AR-1J3861
Ambap69-65-8
BRN 1721898
C00392
C6H14O6
CCRIS 369
CHEBI:16899
CHEMBL689
CID6251
Cordycepate
Cordycepic acid
D-(-)-Mannitol
D-Mannitol
D-Mannitol (JP15)
D-mannite
D-mannitol
D00062
D008353
DL-Mannitol
Diosmol
ED1D1E61-FEFB-430A-AFDC-D1F4A957FC3D
EINECS 200-711-8
EINECS 201-770-2
Fraxinine
HSDB 714
Hexahydroxyhexane
Hexanhexol
Invenex
Isotol
LS-1588
LS-89250
M0044
M1902_SIGMA
M4125_SIAL
M8429_SIAL
M9546_SIAL
M9647_SIAL
MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER
MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45%
 
MANNITOL 25%
MANNITOL 5% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.12%
MLS001335977
MLS001335978
MTL
Manicol
Manitol
Maniton S
Maniton-S
Manna Sugar
Manna sugar
Mannazucker
Mannidex
Mannidex 16700
Mannigen
Mannistol
Mannit
Mannit p
Mannite
Mannitol
Mannitol (USP)
Mannitol (VAN)
Mannitol 10%
Mannitol 10% In Plastic Container
Mannitol 15%
Mannitol 15% In Plastic Container
Mannitol 20%
Mannitol 20% In Plastic Container
Mannitol 5%
Mannitol 5% In Plastic Container
Mannitol [USAN]
Mannitolum
Mannogem 2080
Marine Crystal
Marine crystal
MolPort-003-927-039
Mushroom sugar
NCGC00164246-01
NCI-C50362
NSC 407017
NSC 9256
OSMITROL 10% IN WATER IN PLASTIC CONTAINER
OSMITROL 15% IN WATER IN PLASTIC CONTAINER
OSMITROL 20% IN WATER IN PLASTIC CONTAINER
OSMITROL 5% IN WATER IN PLASTIC CONTAINER
Osmitrol
Osmitrol (TN)
Osmitrol 10% In Water
Osmitrol 15% In Water
Osmitrol 20% In Water
Osmitrol 5% In Water
Osmofundin
Osmosal
Resectisol
Resectisol In Plastic Container
SDM No. 35
SMR000857324
SORBITOL-MANNITOL IN PLASTIC CONTAINER
Sorbitol-Mannitol
TL806434
UNII-3OWL53L36A
ZINC02041302
bmse000099
cpd without stereochemical designation
e 421
e-421
e421
manita
mannitol
4
RibavirinapprovedPhase 494836791-04-537542
Synonyms:
1-.beta.-D-Ribofuranosyl-1,2,4-triazolo-3-carboxamide
1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide
1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide
1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide
1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
1-beta-D-ribofuranosyl-1-H-1,2,4-triazole-3-carboxamide
36791-04-5
437710-49-1
66510-90-5
AA-504/07617051
AB00430481
AC1L1XXZ
AC1Q1IDC
AC1Q4ZGS
AKOS001715163
BB_NC-0567
BPBio1_001195
BRN 0892462
BSPBio_001085
BSPBio_003352
C-Virin
CHEMBL1643
CID37542
Copegus
Copegus (TN)
Cotronak
D00423
DB00811
DRG-0028
DivK1c_000782
Drug: Ribavirin
EU-0101063
FT-0082885
HMS2090L15
HMS2094O09
HMS502H04
HSDB 6513
ICN-1229
IDI1_000782
Ibavyr
KBio1_000782
KBio2_002328
KBio2_004896
KBio2_007464
KBio3_002854
KBioGR_001804
KBioSS_002331
KS-1104
LS-1241
Lopac0_001063
MLS000028486
MLS002222317
Moderiba
MolPort-002-507-104
MolPort-002-885-856
NCGC00090726-01
NCGC00090726-03
NCGC00090726-04
NCGC00090726-05
NCGC00090726-06
NCGC00090726-07
NINDS_000782
 
NSC 163039
NSC163039
Prestwick3_000993
R 9644
R-964
R9644_SIGMA
RBV
RG-964
RIBAV
RTC
RTCA
RTP
Ravanex
Rebetol
Rebetol (TN)
Rebetron
Rebretron
Ribacine
Ribamide
Ribamidil
Ribamidyl
Ribasphere
Ribasphere (TN)
Ribasphere Ribapak
Ribav
Ribavirin
Ribavirin (JAN/USP/INN)
Ribavirin Capsules
Ribavirin Triphosphate
Ribavirin [USAN:INN]
Ribavirin-TP
Ribavirina
Ribavirina [INN-Spanish]
Ribavirine
Ribavirine [INN-French]
Ribavirinum
Ribavirinum [INN-Latin]
Ribovirin
Ro 20-9963/000
Ro-20-9963
S2504_Selleck
SCH 18908
SMP1_000261
SMR000058315
SPECTRUM1503938
SR-01000076112-3
Spectrum3_001876
Spectrum4_001252
Spectrum5_002075
Spectrum_001826
Tribavirin
UNII-49717AWG6K
Varazid
Vilona
Viramid
Viramide
Virazid
Virazide
Virazole
Virazole (Ribavirin) Inhalation Solution
Virazole (TN)
Virazole 5'-triphosphate
ZINC01035331
ribavirin
5
Folic Acidapproved, nutraceuticalPhase 4, Phase 3292459-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic Acid
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
 
Folsaeure
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
6
Thiamineapproved, nutraceuticalPhase 48859-43-81130
Synonyms:
100660-17-1
115461-66-0
1sbr
2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol
2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol chloride
3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydrox yethyl)-4-methylthiazolium chloride
3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-m- ethylthiazolium chloride, monohydrochloride
3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methylthiazolium chloride
3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methylthiazolium chloride monohydrochloride
3-(4-AMINO-2-METHYL-PYRIMIDIN-5-YLMETHYL)-5-(2-HYDROXY-ETHYL)-4-METHYL-THIAZOL-3-IUM
3-(4-AMINO-2-methyl-pyrimidin-5-ylmethyl)-5-(2-hydroxy-ethyl)-4-methyl-thiazol-3-ium
3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-5-(2-hydroxyethyl)-4-methylthiazolium chloride
3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium
3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium chloride
3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium chloride hydrochloride
3[(4-Amino-2-methyl-5-pyrimidinyl)-methyl]-5-(2-hydroxyethyl)-4-methylthiazolium chloride
55463-15-5
57777-32-9
59-43-8
67-03-8
AC-11683
AC1L1ASK
AC1L1LOC
AC1LAODT
AC1Q4V9Q
AI3-18993
AKOS000668650
AR-1L8201
Aneurin
Aneurine
Antiberiberi factor
Apatate drape
Apate drops
B-Amin
BAS 00266240
BPBio1_000686
BSPBio_000622
Beatine
Bedome
Begiolan
Beivon
Benerva
Bequin
Berin
Betabion
Betalin S
Betaxin
Bethiamin
Bethiazine
Beuion
Bevitex
Bevitine
Bewon
Biamine
Bithiamin
Biuno
Bivatin
Bivita
C00378
C12H17N4OS
CCRIS 1906
CCRIS 5823
CHEBI:18385
CHEBI:33283
CHEBI:49105
CHEMBL1547
CHEMBL1588
CID1130
CID517305
CID6042
Cernevit-12
Chloride-hydrochloride salt of thiamine
Clotiamina
D08580
DB00152
EINECS 200-425-3
EINECS 200-641-8
Eskapen
Eskaphen
FEMA No. 3322
HSDB 220
 
Hybee
I14-14339
LS-3226
LT00233141
Lixa-beta
MLS001304099
Metabolin
MolPort-000-722-048
MolPort-001-920-086
MolPort-002-052-059
NChemBio.2007.13-comp10
NSC 36226
NSC36226
Oryzanin
Oryzanine
Prestwick0_000631
Prestwick1_000631
Prestwick2_000631
Prestwick3_000631
SBB058094
SMP1_000084
SMR000718788
SPBio_002841
ST095175
Slowten
THD
THIAMIN, VITAMIN B1
Thiadoxine
Thiamin
Thiamin dichloride
Thiaminal
Thiamine
Thiamine (INN)
Thiamine HCL
Thiamine Hydrochloride
Thiamine [INN:BAN]
Thiamine chloride
Thiamine chloride hydrochloride
Thiamine dichloride
Thiamine hydrochloride [JAN]
Thiamine monochloride
Thiamine monohydrochloride
Thiamine, chloride
Thiamine, chloride, hydrochloride
Thiamine, monohydrochloride
Thiaminium
Thiaminium chloride hydrochloride
Thiaminum
Thiaminum [INN-Latin]
Thiamol
Thiavit
Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-m- ethyl, chloride, monohydrochloride
Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl- chloride
Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl- chloride (1:1)
Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl-, chloride, monohydrochloride
Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl-chloride
Tiamidon
Tiamina
Tiamina [INN-Spanish]
Tiaminal
TimTec1_000613
Trophite
UNII-X66NSO3N35
VIB
Vetalin S
Vinothiam
Vitamin B1
Vitamin B1 (TN)
Vitamin B1 hydrochloride (VAN)
Vitaneurin
Vitaneuron
ZINC00049153
[5-[[5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium-3-yl]methyl]-2-methylpyrimidin-4-yl]azanium dichloride
bmse000274
nchembio.121-comp5
thiamin
thiamine
thiamine(1+)
thiamine(1+) ion
thiaminium
vitamin B1
vitamin b1(thiamine)
7
AcetylcholineexperimentalPhase 468951-84-3187
Synonyms:
ACh
Acetyl choline ion
Acetylcholine Chloride
Acetylcholine cation
 
Acetylcholinium: acetyl-Choline
Choline acetate
Choline acetate (ester)
Miochol E
O-Acetylcholine
acetylcholine chloride
8Pharmaceutical SolutionsPhase 47004
9Peripheral Nervous System AgentsPhase 4, Phase 2, Phase 318510
10AbobotulinumtoxinAPhase 4588
11AntimetabolitesPhase 4, Phase 39454
12Vitamin B ComplexPhase 4, Phase 32847
13Neurotransmitter AgentsPhase 4, Phase 2, Phase 314795
14Cholinergic AgentsPhase 43243
15Botulinum Toxins, Type APhase 4588
16Botulinum ToxinsPhase 4616
17Ophthalmic SolutionsPhase 41006
18IncobotulinumtoxinAPhase 4599
19OnabotulinumtoxinAPhase 4588
20Neuromuscular AgentsPhase 4922
21Antihypertensive AgentsPhase 4, Phase 2, Phase 33618
22VitaminsPhase 43857
23Antiviral AgentsPhase 48071
24Anti-Infective AgentsPhase 417220
25Trace ElementsPhase 43900
26MicronutrientsPhase 43901
27Vitamin B9NutraceuticalPhase 4, Phase 32924
28FolateNutraceuticalPhase 4, Phase 32924
29ThiaminNutraceuticalPhase 488
30
TofacitinibapprovedPhase 395477600-75-2
Synonyms:
Tasocitinib
 
Tofacitinib Citrate
Tofacitinibum
Xeljanz
31
MethotrexateapprovedPhase 314441959-05-2, 59-05-2126941
Synonyms:
4-amino-10-methylfolic acid
4-amino-N(10)-Methylpteroylglutamic acid
Abitrexate
Amethopterin
Amethopterine
Antifolan
Arbitrexate
Emtexate
Folex
HDMTX
L-Amethopterin
Ledertrexate
MTX
Metatrexan
Methopterin
Methotextrate
 
Methotrate
Methotrexat
Methotrexate
Methotrexate Sodium
Methotrexatum
Methylaminopterin
Methylaminopterinum
Metoject
Metotrexato
Mexate
Méthotrexate
N-Bismethylpteroylglutamic Acid
N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid
Otrexup
Rasuvo
Rheumatrex
Rheumatrex Dose Pack
Trexall
32
OndansetronapprovedPhase 2, Phase 328599614-02-54595
Synonyms:
(RS)-1,2,3,9-Tetrahydro-9-methyl-3-(2-methylimidazol-1-ylmethyl)carbazol-4-one
1,2,3,9-Tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-4H-carbazol-4-one
103639-04-9 (mono-hydrochloride dihydrate)
108303-49-7
116002-70-1
9-Methyl-3-(2-methyl-imidazol-1-ylmethyl)-1,2,3,9-tetrahydro-carbazol-4-one
9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one
9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one
99614-01-4 (mono-hydrochloride)
99614-02-5
AB00373674
AC1L1IIM
AKOS000599484
Apo-ondansetron
BAS 00717177
BPBio1_001118
BRD-A19736161-001-01-8
BRD-A19736161-003-03-0
BRN 3622981
BSPBio_001016
C07325
C18H19N3O
CBDivE_008994
CHEMBL46
CID4595
CPD001307702
D00456
DB00904
DESMETHYLONDANSETRON
GR 38032
GR 38032X
GR-38032F
GR38032F
HMS2090H16
I06-0687
I06-1329
L000456
 
LS-172305
LS-51878
MolPort-001-944-253
NCI60_022780
Novo-ondansetron
Ondansetron
Ondansetron (JAN/USP/INN)
Ondansetron Hydrochloride
Ondansetron [USAN:INN:BAN]
Ondansetron hydrochloride dihydrate
Ondansetron, (+,-)-Isomer
Oprea1_435466
Oprea1_852372
PHL-ondansetron
PMS-ondansetron
Prestwick0_001058
Prestwick1_001058
Prestwick2_001058
Prestwick3_001058
Ratio-ondansetron
SAM002589958
SN-307
SPBio_002938
STK370548
STOCK4S-10990
Sandoz ondansetron
TL8006071
TimTec1_001750
UNII-4AF302ESOS
ZOFRAN IN PLASTIC CONTAINER
Zofran
Zofran ODT
Zofran ODT (TN)
Zofran odt
Zophren
Zudan
Zuplenz
ondansetron
ondansetron (Zofran)
33Immunosuppressive AgentsPhase 3, Phase 210422
34Nucleic Acid Synthesis InhibitorsPhase 33836
35Gastrointestinal AgentsPhase 2, Phase 36401
36AnestheticsPhase 2, Phase 3, Phase 07385
37Protein Kinase InhibitorsPhase 33162
38Immunologic FactorsPhase 3, Phase 218483
39Anti-Inflammatory AgentsPhase 3, Phase 28478
40Antirheumatic AgentsPhase 3, Phase 28496
41Antimetabolites, AntineoplasticPhase 35770
42Folic Acid AntagonistsPhase 31643
43Dermatologic AgentsPhase 3, Phase 24555
44
SerotoninPhase 2, Phase 3314750-67-95202
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
 
5-Hydroxy-tryptamine
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
Antemovis
DS substance
Enteramin
Enteramine
45Serotonin AntagonistsPhase 2, Phase 31175
46Tranquilizing AgentsPhase 2, Phase 33597
47Serotonin AgentsPhase 2, Phase 32668
48Psychotropic DrugsPhase 2, Phase 35501
49Anti-Anxiety AgentsPhase 2, Phase 31529
50AntipruriticsPhase 2, Phase 3619

Interventional clinical trials:

(show all 48)
idNameStatusNCT IDPhase
1Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study)CompletedNCT02176356Phase 4
2Effect of Xiaoer Jiebiao Oral Liquid on Hand-foot-mouth DiseaseRecruitingNCT02328651Phase 4
3Effects of Functional Electrical Stimulation on Gait in Children With Cerebral PalsyNot yet recruitingNCT02462018Phase 4
4Thiamin Deficiency in Obese Thai ChildrenNot yet recruitingNCT02464865Phase 4
5Evaluation of the Safety and Performance of the NESS L300 Plus SystemCompletedNCT01237860Phase 3
6Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) In Patients With Rheumatoid Arthritis Who Have Not Previously Received MTXCompletedNCT01039688Phase 3
7Multi-pad FES System for Drop Foot TreatmentRecruitingNCT02729636Phase 2, Phase 3
8Intravenous Ondansetron to Attenuate the Hypotensive, Bradycardic Response to Spinal Anesthesia in Healthy ParturientsEnrolling by invitationNCT01414777Phase 2, Phase 3
9Functional Electrical Stimulation for Footdrop in HemiparesisCompletedNCT00148343Phase 2
10Effect of Robot-assisted Training on Foot Drop in Multiple SclerosisCompletedNCT00872053Phase 1, Phase 2
11Extracorporeal Shockwave Treatment for Chronic Soft Tissue WoundsCompletedNCT00545896Phase 2
12The Role of Cytokines on Growth Hormone Suppression in Premenopausal Women With Rheumatoid Arthritis and the Effect of Treatment With EtanerceptCompletedNCT00034060Phase 2
13Ankle Robot to Reduce Foot-drop in StrokeRecruitingNCT02483676Phase 2
14Essential Oils for Enhancing QOL in ASDRecruitingNCT02543203Phase 2
15Targeted Lower Extremity Joint TrainingTerminatedNCT00765544Phase 1, Phase 2
16Pilot Study Assessing the Feasibility of Treating Foot Drop With the Neurostep™ System.CompletedNCT00860210Phase 1
17Electrical Stimulation for Recovery of Ankle Dorsiflexion in Chronic Stroke SurvivorsCompletedNCT01029912Phase 1
18Functional Electrical Stimulation Mediated Neuroplasticity: Lower Extremity CCNMES in StrokeRecruitingNCT02199795Phase 1
19Walking With FES or AFO in People With MS With Foot DropCompletedNCT01977287
20Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot DropCompletedNCT01138995
21Evaluation of Dual Channel vs. Single Channel FES for DropfootCompletedNCT02494323
22Clinical Study to Evaluate the Implantation of the ActiGait Drop Foot Stimulator SystemCompletedNCT01116466
23Effects of Targeted Lower Extremity Joint Training on Multiple Sclerosis (MS) Gait AbnormalitiesCompletedNCT00906737
24WalkAide Compared to Ankle-Foot Orthosis (AFO) in Stroke PatientsCompletedNCT01087957
25Efficacy of the WalkAide and AFOs for CVACompletedNCT00216320
26Tibial Nerve Versus Sciatic Nerve BlockCompletedNCT01415193
27Comparison Between Implanted Functional Electrical Stimulation and Foot OrthosisCompletedNCT01415700
28Approach to Continuous Sciatic Nerve Block for Orthopedic Procedures in Day Surgery With Two Different TechniquesCompletedNCT02029404
29Effects of Weight Loss on Foot Structure and Function in Obese Adults: A Pilot StudyCompletedNCT01782144
30Treatment of Painful Diabetic Neuropathy With Photon StimulationCompletedNCT00539175
31PAHA Study: Psychological Active and Healthy AgeingCompletedNCT01966562
32Effects of Two Different Types of Ankle Foot Orthoses on Gait Outcomes in Patients With Subacute Stroke.RecruitingNCT02693834
33Functional Electrical Stimulation for People With Multiple Sclerosis Who Experience Foot DropRecruitingNCT01914016
34Extramembranous and Interosseous Technique of Tibialis Posterior Tendon TransferRecruitingNCT01751503
35Effect of FES Interventions on Gait Dynamics in Stroke PopulationRecruitingNCT01952613
36Comparison of Different Treatment Methods for Gait Rehabilitation of Sub-Acute Post Stroke Patients With Dropped FootRecruitingNCT01876030
37Interactive Exoskeleton Robot for Walking - Ankle JointRecruitingNCT02471248
38A Clinical Trial to Evaluate the Effectiveness and Safety of Xiyanping Injection in the Treatment of Mild Type of Hand, Foot, and Mouth DiseaseRecruitingNCT01182025
39Pathological Basis of MRI Signal Changes in Multiple SclerosisRecruitingNCT02659956
40A Surveillance Study of Diseases Specified as Adverse Events of Specific Interest (AESI) and Serious Adverse Events (SAEs) in Children in Africa Prior to Implementation of the RTS,S/AS01E Candidate VaccineRecruitingNCT02374450
41Chromosome 18 Clinical Research CenterRecruitingNCT00227253
42Treating Foot Drop in People With Multiple Sclerosis Using Electrical StimulationActive, not recruitingNCT02123537
43Study of Changes in the Feet With PregnancyActive, not recruitingNCT01868074
44Evaluation of Usability and Human Factors in the Novus SystemNot yet recruitingNCT02738242
45Eccentric Exercise for Chronic Mid-portion Achilles TendinopathyNot yet recruitingNCT01225497
46The Effects of Ankle Foot Orthoses on Gait Efficiency in Children With Acute Lymphoblastic Leukemia and Foot DropTerminatedNCT01001390
47Continuous Femoral and Tibial Nerve Blocks in TKA PatientsTerminatedNCT01680692Phase 0
48A Clinical Study to Assess a Compression Device in Patients With Venous Leg UlcersWithdrawnNCT02561013

Search NIH Clinical Center for Foot Drop

Genetic Tests for Foot Drop

About this section

Anatomical Context for Foot Drop

About this section

MalaCards organs/tissues related to Foot Drop:

33
Bone, Brain, Spinal cord, Breast, Prostate, T cells, Lung

Animal Models for Foot Drop or affiliated genes

About this section

Publications for Foot Drop

About this section

Articles related to Foot Drop:

(show top 50)    (show all 287)
idTitleAuthorsYear
1
The anti-inflammatory activity of curcumin protects the genital mucosal epithelial barrier from disruption and blocks replication of HIV-1 and HSV-2. (25856395)
2015
2
SjAPgren's syndrome associated dry eye in a mouse model is ameliorated by topical application of integrin I+4 antagonist GW559090. (26463157)
2015
3
Bio-sheet graft therapy for artificial gastric ulcer after endoscopic submucosal dissection: an animal feasibility study. (25484327)
2015
4
Complete Remission in Systemic Skin Interdigitating Dendritic Cell Sarcoma after ABVD Chemotherapy. (26106005)
2015
5
Crystal structure of the tetrameric fibrinogen-like recognition domain of fibrinogen C domain containing 1 (FIBCD1) protein. (24293368)
2014
6
Bladder dysfunction induced by cerebral hypoperfusion after bilateral common carotid artery occlusion in rats. (24820447)
2014
7
Duchenne/Becker muscular dystrophy: A report on clinical, biochemical, and genetic study in Gujarat population, India. (25221400)
2014
8
Identification of an LGP2-associated MDA5 agonist in picornavirus-infected cells. (24550253)
2014
9
Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphoma. (23144193)
2013
10
Allele-specific N-glycosylation delays human surfactant protein B secretion in vitro and associates with decreased protein levels in vivo. (24002332)
2013
11
Air pollution and individual and neighborhood socioeconomic status: evidence from the Multi-Ethnic Study of Atherosclerosis (MESA). (24076625)
2013
12
ACBD3 interaction with TBC1 domain 22 protein is differentially affected by enteroviral and kobuviral 3A protein binding. (23572552)
2013
13
Pseudogene OCT4-pg4 functions as a natural micro RNA sponge to regulate OCT4 expression by competing for miR-145 in hepatocellular carcinoma. (23615404)
2013
14
MicroRNA-155 drives TH17 immune response and tissue injury in experimental crescentic GN. (23949802)
2013
15
Acromegaly: Beyond surgery. (23961470)
2013
16
Vaccines against botulism. (22694934)
2012
17
Balloon-assisted enteroscopy with prophylactic polypectomy for Peutz-Jeghers syndrome: experience in Taiwan. (21086168)
2011
18
The Nance-Horan syndrome protein encodes a functional WAVE homology domain (WHD) and is important for co-ordinating actin remodelling and maintaining cell morphology. (20332100)
2010
19
The predictors of the presence of varices in patients with primary sclerosing cholangitis. (20044810)
2010
20
Histamine N-methyltransferase 939A>G polymorphism affects mRNA stability in patients with acetylsalicylic acid-intolerant chronic urticaria. (19178400)
2009
21
UVB upregulates the bax promoter in immortalized human keratinocytes via ROS induction of Id3. (19054058)
2009
22
Estradiol increases guanosine 5'-triphosphate cyclohydrolase expression via the nitric oxide-mediated activation of cyclic adenosine 5'-monophosphate response element binding protein. (19389836)
2009
23
Gain-of-function PDGFRA mutations, earlier reported in gastrointestinal stromal tumors, are common in small intestinal inflammatory fibroid polyps. A study of 60 cases. (19448595)
2009
24
Evidence for a novel x-linked modifier locus for leber hereditary optic neuropathy. (18363168)
2008
25
Nuclear imaging of prostate cancer with gastrin-releasing-peptide-receptor targeted radiopharmaceuticals. (18991717)
2008
26
High level expression of STAG1/PMEPA1 in an androgen-independent prostate cancer PC3 subclone. (17318295)
2007
27
Effect of endothelin 1 genotype on blood pressure is dependent on physical activity or fitness levels. (17938376)
2007
28
The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera. (17389763)
2007
29
Genetic polymorphisms for vascular endothelial growth factor in perinatal complications. (17353160)
2006
30
Supramolecular assemblies and molecular recognition of amphiphilic schiff bases with barbituric acid in organized molecular films. (16851253)
2005
31
Highly altered protein expression profile in the adriamycin resistant MCF-7 cell line. (15253420)
2004
32
Cataracts and glaucoma in patients with oculocerebrorenal syndrome. (12963605)
2003
33
Problems with eating and drinking in patients with unilateral peripheral facial paralysis. (14571331)
2003
34
Adrenal metastatic placental site trophoblastic tumor. Case report. (12744102)
2003
35
Paraneoplastic pemphigus. (11589740)
2001
36
Congenital fetal neuroblastoma]. (11223566)
2001
37
Metanephric adenoma, nephrogenic rests, and Wilms' tumor: a histologic and immunophenotypic comparison. (11688464)
2001
38
Atmospheric pressure ion mobility spectrometry of protonated and sodiated peptides. (10390859)
1999
39
Regulation of avian precardiac mesoderm development by insulin and insulin-like growth factors. (8647921)
1996
40
In vitro inhibition of mammary cell growth by lactoferrin: a comparative study. (7990656)
1994
41
Adenosine stimulates DNA fragmentation in human thymocytes by Ca(2+)-mediated mechanisms. (7818494)
1994
42
Dual modes of control of c-fos mRNA induction by intracellular calcium in T cells. (8007962)
1994
43
Retroviral gene transduction of circulating progenitor cells in patients with metastatic breast cancer. (8252190)
1993
44
Nonbiased identification of DNA sequences that bind thyroid hormone receptor alpha 1 with high affinity. (8366086)
1993
45
L-type voltage-sensitive calcium channels mediate synaptic activation of immediate early genes. (1657056)
1991
46
Toxic encephalopathy caused by topically applied diphenhydramine. (3712143)
1986
47
Screening for malignant hyperthermia susceptibility. (6930029)
1980
48
Necrotising aspergillosis complicating fulminating viral pneumonia. (6992331)
1980
49
Paths of lysine degradation in patients with hyperlysinemia. (6074139)
1967
50
Thromboangiitis obliterans in two brothers. (14952874)
1952

Variations for Foot Drop

About this section

Expression for genes affiliated with Foot Drop

About this section
Search GEO for disease gene expression data for Foot Drop.

Pathways for genes affiliated with Foot Drop

About this section

GO Terms for genes affiliated with Foot Drop

About this section

Sources for Foot Drop

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet